291 related articles for article (PubMed ID: 7722511)
1. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study.
Massieu L; Morales-Villagrán A; Tapia R
J Neurochem; 1995 May; 64(5):2262-72. PubMed ID: 7722511
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures.
Velasco I; Tapia R; Massieu L
J Neurosci Res; 1996 Jun; 44(6):551-61. PubMed ID: 8794946
[TBL] [Abstract][Full Text] [Related]
4. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo.
Massieu L; Tapia R
J Neurochem; 1997 Sep; 69(3):1151-60. PubMed ID: 9282938
[TBL] [Abstract][Full Text] [Related]
5. Effects of ionotropic excitatory amino acid receptor antagonists on glutamate transport and transport-mediated changes in extracellular excitatory amino acids in the rat striatum.
Bloc A; Samuel D; Forni C; Dusticier N; Kerkerian-Le Goff L
J Neurochem; 1995 Apr; 64(4):1598-604. PubMed ID: 7891087
[TBL] [Abstract][Full Text] [Related]
6. Loss of GABAergic neuronal phenotype in primary cerebellar cultures following blockade of glutamate reuptake.
Kovács AD; Cebers G; Cebere A; Liljequist S
Brain Res; 2003 Jul; 977(2):209-20. PubMed ID: 12834881
[TBL] [Abstract][Full Text] [Related]
7. Glutamate transport blockade has a differential effect on AMPA and NMDA receptor-mediated synaptic transmission in the developing barrel cortex.
Kidd FL; Isaac JT
Neuropharmacology; 2000 Mar; 39(5):725-32. PubMed ID: 10699439
[TBL] [Abstract][Full Text] [Related]
8. Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons.
Himi T; Ikeda M; Yasuhara T; Murota SI
J Neurosci Res; 2003 Mar; 71(5):679-88. PubMed ID: 12584726
[TBL] [Abstract][Full Text] [Related]
9. Effects of increased extracellular glutamate levels on the local field potential in the brain of anaesthetized rats.
Obrenovitch TP; Urenjak J; Zilkha E
Br J Pharmacol; 1997 Sep; 122(2):372-8. PubMed ID: 9313949
[TBL] [Abstract][Full Text] [Related]
10. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired.
Sánchez-Carbente MR; Massieu L
J Neurochem; 1999 Jan; 72(1):129-38. PubMed ID: 9886063
[TBL] [Abstract][Full Text] [Related]
11. Neuronal damage and MAP2 changes induced by the glutamate transport inhibitor dihydrokainate and by kainate in rat hippocampus in vivo.
Arias C; Arrieta I; Massieu L; Tapia R
Exp Brain Res; 1997 Oct; 116(3):467-76. PubMed ID: 9372295
[TBL] [Abstract][Full Text] [Related]
12. Continuous administration of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion.
Liévens JC; Dutertre M; Forni C; Salin P; Kerkerian-Le Goff L
Brain Res Mol Brain Res; 1997 Oct; 50(1-2):181-9. PubMed ID: 9406933
[TBL] [Abstract][Full Text] [Related]
13. Cerebral neurons of transgenic ALS mice are vulnerable to glutamate release stimulation but not to increased extracellular glutamate due to transport blockade.
Tovar-y-Romo LB; Tapia R
Exp Neurol; 2006 Jun; 199(2):281-90. PubMed ID: 16364298
[TBL] [Abstract][Full Text] [Related]
14. Dihydrokainate-sensitive neuronal glutamate transport is required for protection of rat cortical neurons in culture against synaptically released glutamate.
Wang GJ; Chung HJ; Schnuer J; Lea E; Robinson MB; Potthoff WK; Aizenman E; Rosenberg PA
Eur J Neurosci; 1998 Aug; 10(8):2523-31. PubMed ID: 9767383
[TBL] [Abstract][Full Text] [Related]
15. Evidence for neuronal origin and metabotropic receptor-mediated regulation of extracellular glutamate and aspartate in rat striatum in vivo following electrical stimulation of the prefrontal cortex.
Lada MW; Vickroy TW; Kennedy RT
J Neurochem; 1998 Feb; 70(2):617-25. PubMed ID: 9453555
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Pintor A; Galluzzo M; Grieco R; Pèzzola A; Reggio R; Popoli P
J Neurochem; 2004 Apr; 89(1):152-6. PubMed ID: 15030399
[TBL] [Abstract][Full Text] [Related]
17. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
[TBL] [Abstract][Full Text] [Related]
18. Effects of uptake carrier blockers SK & F 89976-A and L-trans-PDC on in vivo release of amino acids in rat hippocampus.
Zuiderwijk M; Veenstra E; Lopes da Silva FH; Ghijsen WE
Eur J Pharmacol; 1996 Jul; 307(3):275-82. PubMed ID: 8836615
[TBL] [Abstract][Full Text] [Related]
19. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
Massieu L; Tapia R
Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
[TBL] [Abstract][Full Text] [Related]
20. L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade.
Rawls SM; McGinty JF
J Neurochem; 1997 Apr; 68(4):1553-63. PubMed ID: 9084426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
